Form 4 for ELV Elevance Health
Accepted 2022-11-04 00:00:00 ET · period of report 2022-11-04 · accession 0001156039-22-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-04 | 2022-11-04 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 111.4K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-04 | G | D | 10,000 | $0.00 | 111,415 | D | — | — | (F1) Balance includes 252.31 shares acquired on March 25, 2022, 257.62 shares acquired on June 24, 2022 and 266.45 shares acquired on September 23, 2022 through a dividend reinvestment plan. |